1. Home
  2. Browse
  3. HRA001221
HRA001221
   HRA001221.xlsx
Title:
Telomerase positive circulating tumor cells are associated with poor prognosis via neutrophil-mediated inflammatory immune environment in glioma
Release date:
2021-08-27
Description:
Gliomas are the most common aggressive cancer in the central nervous system. Considering the difficulty in monitoring glioma response and progression, it is necessary to establish an approach for evaluating the progression or survival of patients with glioma. We propose an application that is easier for clinical detection and treatment monitoring in glioma patients by using telomerase-positive circulating tumor cells (CTCs) and further evaluate the relationship between the immune microenvironment and CTCs in glioma patients
Data Accessibility:   
Controlled access Request Data
BioProject:
PRJCA006314
Study type:
Disease Study
Disease name:
brain glioma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
HDAC000736
DAC name:
Glioma
Contact person:
Zhang Wen
Email:
zhangwen@cicams.ac.cn
Description:
Glioma project
Individuals & samples
Files
Request Data
Submitter:   Zhang Kaitai / zhangkt@cicams.ac.cn
Organization:   Cancer Hospital, Chinese Academy of Medical Sciences
Submission date:   2021-08-26
Requests:   -